Literature DB >> 31250730

Pharmacogenomics education in medical and pharmacy schools: conclusions of a global survey.

Nataša Karas Kuželički1, Irena Prodan Žitnik1, David Gurwitz2, Adrian Llerena3, Ingolf Cascorbi4, Sofia Siest5, Maurizio Simmaco6, Marc Ansari7,8, Mario Pazzagli9, Chiara Di Resta10,11, Ivan Brandslund12, Matthias Schwab13,14,15, Pieter Vermeersch16, Jeantine E Lunshof17,18,19, George Dedoussis20, Christodoulos S Flordellis21, Uwe Fuhr22, Julia C Stingl23, Ron Hn van Schaik24,25, Vangelis G Manolopoulos26, Janja Marc1.   

Abstract

Aim: The need for pharmacogenomic education is becoming more and more urgent. Our aim was to evaluate the progress in pharmacogenomics education since then, and to put forward further recommendations.
Methods: A survey was sent to 248 schools of medicine, pharmacy, nursing and health professions around the world.
Results: The majority of the study programs (87%) include pharmacogenomics education, which is generally taught as part of the pharmacology curriculum. On average, educators and teachers have selected appropriate and highly relevant pharmacogenomics biomarkers to include in their teaching programs. Conclusions: Based on the results, we can conclude that the state of pharmacogenomics education at the surveyed universities has improved substantially since 2005.

Keywords:  education; global survey; medicine; pharmacogenomics; pharmacy; recommendations

Mesh:

Year:  2019        PMID: 31250730     DOI: 10.2217/pgs-2019-0009

Source DB:  PubMed          Journal:  Pharmacogenomics        ISSN: 1462-2416            Impact factor:   2.533


  10 in total

1.  Perception of personalized medicine, pharmacogenomics, and genetic testing among undergraduates in Hong Kong.

Authors:  Nicholas Yan Chai Cheung; Jasmine Lee Fong Fung; Yvette Nga Chung Ng; Wilfred Hing Sang Wong; Claudia Ching Yan Chung; Christopher Chun Yu Mak; Brian Hon Yin Chung
Journal:  Hum Genomics       Date:  2021-08-18       Impact factor: 4.639

2.  Providers' perspectives on the clinical utility of pharmacogenomic testing in pediatric patients.

Authors:  Ina Liko; Yee Ming Lee; Danielle L Stutzman; Allison B Blackmer; Kimberly M Deininger; Ann M Reynolds; Christina L Aquilante
Journal:  Pharmacogenomics       Date:  2021-03-04       Impact factor: 2.533

3.  Anesthesia providers as stakeholders to adoption of pharmacogenomic information in perioperative care.

Authors:  Tien M Truong; Jeffrey L Apfelbaum; Emily Schierer; Keith Danahey; Brittany A Borden; Theodore Karrison; Sajid Shahul; Magdalena Anitescu; Rebecca Gerlach; Randall W Knoebel; David O Meltzer; Mark J Ratain; Peter H O'Donnell
Journal:  Pharmacogenet Genomics       Date:  2022-04-01       Impact factor: 2.089

Review 4.  Engaging pharmacogenomics in pain management and opioid selection.

Authors:  David R Bright; Natasha Petry; Eric Roath; Tyler Gibb
Journal:  Pharmacogenomics       Date:  2021-09-15       Impact factor: 2.638

5.  Pharmacogenomics Implementation and Hurdles to Overcome; In the Context of a Developing Country.

Authors:  Nayyereh Ayati; Monireh Afzali; Mandana Hasanzad; Abbas Kebriaeezadeh; Ali Rajabzadeh; Shekoufeh Nikfar
Journal:  Iran J Pharm Res       Date:  2021       Impact factor: 1.696

6.  The Efficacy of a Didactic and Case-Based Pharmacogenomics Education Program on Improving the Knowledge and Confidence of Alberta Pharmacists.

Authors:  Meagan Hayashi; Sherif Hanafy Mahmoud; Dalia A Hamdy
Journal:  Pharmgenomics Pers Med       Date:  2022-04-23

7.  Investigation of Biomedical Students' Attitudes toward Pharmacogenomics and Personalized Medicine: A Cross-Sectional Study.

Authors:  Josipa Bukic; Doris Rusic; Dario Leskur; Ana Seselja Perisin; Tin Cohadzic; Marko Kumric; Josko Bozic; Darko Modun
Journal:  Pharmacy (Basel)       Date:  2022-06-28

Review 8.  Pharmacogenomic testing in paediatrics: Clinical implementation strategies.

Authors:  Charlotte I S Barker; Gabriella Groeneweg; Anke H Maitland-van der Zee; Michael J Rieder; Daniel B Hawcutt; Tim J Hubbard; Jesse J Swen; Bruce C Carleton
Journal:  Br J Clin Pharmacol       Date:  2022-02-07       Impact factor: 3.716

9.  Pharmacogenomic biomarker information differences between drug labels in the United States and Hungary: implementation from medical practitioner view.

Authors:  Reka Varnai; Istvan Szabo; Greta Tarlos; Laszlo Jozsef Szentpeteri; Attila Sik; Sandor Balogh; Csilla Sipeky
Journal:  Pharmacogenomics J       Date:  2019-12-02       Impact factor: 3.550

10.  Knowledge and Attitudes of Medical and Health Science Students in the United Arab Emirates toward Genomic Medicine and Pharmacogenomics: A Cross-Sectional Study.

Authors:  Azhar T Rahma; Mahanna Elsheik; Iffat Elbarazi; Bassam R Ali; George P Patrinos; Maitha A Kazim; Salma S Alfalasi; Luai A Ahmed; Fatma Al Maskari
Journal:  J Pers Med       Date:  2020-10-24
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.